The Medical Travel Company completes a €3.8M round to advance its medical solution

The UK and India-based
medical travel startup, The Medical Travel Company (TMTC),
has raised €3.8 million to bring a new full-stack medical solution, offering UK
patients world-class and affordable treatments in India. The round was led by Nexus Venture Partners,
with participation from 4CAST, an
athlete-led investment collective group co-founded by England cricket stars Ben
Stokes and Jofra Archer, along with Indian cricketer KL Rahul.

The Medical Travel Company offers a full-stack platform for medical travel,
enabling UK patients awaiting elective care to access high-quality, lower-cost
treatment in India. The service includes UK doctor involvement throughout the
care pathway, post-surgery insurance, and finish-to-finish logistics across travel,
in-houtilize aftercare, and recovery. The company reports steady utilizer growth and
indusattempt recognition for its role in cross-border care.

Demand is rising, with about 7.7 million people
in the UK facing long waits for elective procedures as of June 2025, including
orthopaedics, dental, IVF, gynaecology, ophthalmology and urology. With private
care often unaffordable, more than 500,000 UK residents travel abroad each year
for rapider, lower-cost treatment. Yet the broader medical tourism market
remains fragmented, with opaque pricing, variable quality standards, and
limited aftercare that can increase uncertainty and risk.

Founded by Sahil Jain and Ankit Mehrotra, the
Medical Travel Company addresses these gaps with a structured, clinician-led
model. UK doctors remain involved before, during, and after treatment. Patients are connected to internationally trained clinicians in globally accredited
hospitals, and a 12-month post-surgery insurance policy is valid back in the UK
through a network of private hospitals. The experience is fully managed, with
personalised aftercare and concierge logistics to provide a seamless journey.

The company plans to utilize new funding to expand
and deepen clinical partnerships in the UK to strengthen patient trust,
establish certified treatment pathways for safer medical travel, and build
technology to maintain complete medical records, supporting continuity of care
when patients return home.

Source link